EU antitrust regulators scrutinize J&J, Novartis units

The European Commission has taken formal steps to advance an antitrust investigation involving subsidiaries of Johnson & Johnson and Novartis concerning the painkiller fentanyl. "If our preliminary conclusions are confirmed, the Dutch subsidiaries of Johnson & Johnson and Novartis entered into a so-called 'co-promotion' agreement to avoid competing against each other, depriving users of fentanyl in the Netherlands from access to a cheaper pain killer," an EC official said in a statement. Both companies said they acted properly, and they will have the opportunity to examine the EC's files, make comments and seek a hearing.

View Full Article in: · New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR